Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
Authors
Keywords
-
Journal
Journal of Laboratory Physicians
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2022-10-21
DOI
10.1055/s-0042-1757723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019
- (2022) Le Wang et al. Frontiers in Public Health
- Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program
- (2022) Vaitheeswaran Kulothungan et al. BMC CANCER
- Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer
- (2022) Xavier Filella et al. CLINICA CHIMICA ACTA
- Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis
- (2022) Luisa Agnello et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers
- (2022) Catarina Leitão et al. Journal of Clinical Medicine
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Percentage of [−2]Pro–Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests
- (2021) Manuel M. Garrido et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
- (2021) Hwanik Kim et al. Scientific Reports
- Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer
- (2021) Yi-Shuo Wu et al. ASIAN JOURNAL OF ANDROLOGY
- Beyond PSA: The Role of Prostate Health Index (phi)
- (2020) Matteo Ferro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
- (2020) Yung-Ting Cheng et al. Scientific Reports
- Active surveillance in intermediate risk prostate cancer
- (2019) Laurence Klotz BJU INTERNATIONAL
- Biomarkers for prostate cancer: prostate-specific antigen and beyond
- (2019) Michael J. Duffy CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings
- (2018) Peter K.-F. Chiu et al. EUROPEAN UROLOGY
- Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation
- (2017) Adam S. Feldman et al. JOURNAL OF UROLOGY
- Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting
- (2017) Jay White et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
- (2017) I. Vukovic et al. International Braz J Urol
- Recent progress and perspectives on prostate cancer biomarkers
- (2016) Shingo Hatakeyama et al. International Journal of Clinical Oncology
- Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations
- (2015) Stacy Loeb BJU INTERNATIONAL
- Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis
- (2014) Wenying Wang et al. Scientific Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now